Cian Healthcare Limited has received in-principle approval from the BSE for issuing equity shares as part of its resolution plan, a significant move toward its operational revival. The plan, approved by the National Company Law Tribunal (NCLT) on December 18, 2025, involves issuing over 2.37 crore shares to prospective promoters and 12.5 lakh shares to public shareholders.
This development is a crucial step as Cian Healthcare navigates its post-insolvency period. The BSE’s approval is a prerequisite for listing the newly issued shares, signaling progress towards operational normalcy and capital restructuring. It marks a key milestone in the company’s journey toward potentially relisting its shares after its Corporate Insolvency…